Nautilus to Participate in the 42nd Annual Cowen Health Care Conference
February 16 2022 - 4:05PM
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a
company pioneering a single-molecule protein analysis platform for
quantifying the proteome, today announced the company will be
participating virtually in the upcoming 42nd Annual Cowen Health
Care Conference.
Nautilus’ management is scheduled to present on Monday, March
7th at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time. Interested
parties may access a live and archived webcast of the presentation
on the company’s website at:
https://www.nautilus.bio/investors/
About Nautilus Biotechnology, Inc.
Based in Seattle, Washington, Nautilus is a development stage
life sciences company creating a platform technology for
quantifying and unlocking the complexity of the proteome. Nautilus’
mission is to transform the field of proteomics by democratizing
access to the proteome and enabling fundamental advancements across
human health and medicine. To learn more about Nautilus, visit
www.nautilus.bio
Contacts
Investors:InvestorRelations@nautilus.bio
Media:Thermal for Nautilus BiotechnologyKaustuva
DasPress@nautilus.bio
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Apr 2023 to Apr 2024